Skip to main content

Table 1 Baseline characteristics and demographics of patients with acute CSC

From: Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy

  STMP Group Half-dose PDT Group P value
Variables (n = 18) (n = 21)  
Age, mean ± SD, (years) 37.22 ± 7.83 38.76 ± 8.08 0.582
Gender, (n)
 Male 13 14  
 Female 5 7 0.742
Duration of symptoms,
 mean ± SD, (days) 25.06 ± 16.09 21.33 ± 15.63 0.359
Baseline BCVA, mean ± SD,
  (ETDRS) 63.67 ± 9.79 62.81 ± 8.52 0.772
Baseline CFT, mean ± SD,
  (μm) 427.28 ± 52.23 423.38 ± 47.39 0.808
Baseline retinal
 sensitivity, mean ± SD, (dB) 12.29 ± 1.88 12.61 ± 1.95 0.601
 Presence of macular PED, (n) 3(16.7%) 5(23.8%) 0.702
Location of leakage site, (n)
 Subfoveal 2 4  
 Juxtafoveal 14 15  
 Extrafoveal 2 2 0.789
Number of leakage point, (n)
 1 15 16  
 2 3 4  
 3 0 1 0.622
  1. CSC central serous chorioretinopathy, STMP subthreshold micropulse, PDT photodynamic therapy, SD standard deviation, BCVA best-corrected visual acuity, ETDRS Early Treatment Diabetic Retinopathy Study, CFT central foveal thickness, PED pigment epithelial detachment